Department of Medicine, Cardiology Division Medical College of Wisconsin, Milwaukee, WI 53226, United States.
J Mol Cell Cardiol. 2012 Apr;52(4):814-21. doi: 10.1016/j.yjmcc.2011.10.003. Epub 2011 Oct 12.
Atherosclerosis of conduit epicardial arteries is the principal culprit behind the complications of coronary heart disease, but a growing body of literature indicates that the coronary microcirculation also contributes substantially to the pathophysiology of cardiovascular disease. An understanding of mechanisms regulating microvascular function in humans is an essential foundation for understanding the role in disease, especially since these regulatory mechanisms vary substantially across species and vascular beds. In fact all subjects whose coronary tissue was used in the studies described have medical conditions that warrant cardiac surgery, thus relevance to the normal human must be inferential and is based on tissue from subjects without known arteriosclerotic disease. This review will focus on recent advances in the physiological and pathological mechanisms of coronary microcirculatory control, describing a robust plasticity in maintaining endothelial control over dilation, including mechanisms that are most relevant to the human heart. This article is part of a Special Issue entitled "Coronary Blood Flow".
心外膜大冠状动脉粥样硬化是冠心病并发症的主要罪魁祸首,但越来越多的文献表明,冠状动脉微循环也对心血管疾病的病理生理学有重要贡献。了解调节人类微血管功能的机制是理解其在疾病中的作用的重要基础,特别是因为这些调节机制在物种和血管床之间有很大的差异。事实上,所有在描述的研究中使用过冠状动脉组织的对象都有需要心脏手术的医疗条件,因此与正常人类的相关性必须是推断性的,并且是基于没有已知动脉粥样硬化疾病的对象的组织。这篇综述将集中讨论冠状动脉微循环控制的生理和病理机制的最新进展,描述了维持内皮细胞对扩张控制的强大可塑性,包括与人类心脏最相关的机制。本文是一个题为“冠状动脉血流”的特刊的一部分。